Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

01/02/2019 06:00

Feb 1 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2018        Dec 31, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             8.09                8.39              11.10     
                 (-3.6 pct)          (+0.6 pct)        (+1.8 pct)   
  Operating        67 mln               7 mln         loss 510 mln  
                (+849.4 pct)         (-90.0 pct)                    
  Recurring        102 mln             29 mln         loss 510 mln  
                (+246.3 pct)         (-74.0 pct)                    
  Net              191 mln             13 mln         loss 380 mln  
                                     (-82.3 pct)                    
  EPS             5.53 yen            0.38 yen       loss 10.95 yen 
  Ann Div                             3.00 yen                      
  -Q2 div            NIL                 NIL                        
  -Q4 div                             3.00 yen                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T